APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Injection Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intravenous Injection Immunoglobulin Industry Growth and Trends Forecast to 2032

Report ID 174004300131 December 202595 pages

Choose your research edition.

Industry ResearchIntravenous Injection Immunoglobulin Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Injection Immunoglobulin Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Intravenous Injection Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Injection Immunoglobulin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Injection Immunoglobulin Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Intravenous Injection Immunoglobulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intravenous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intravenous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous Injection Immunoglobulin include Boya-Bio, CTBB, Sinopharm, Beijing Tiantan Biological Products, Guangdong Shuagnlin Bio-pharmacy, Hualan Bio, Nanyue Biopharming, Shanghai RAAS and Weiguang Biological, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intravenous Injection Immunoglobulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intravenous Injection Immunoglobulin market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intravenous Injection Immunoglobulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intravenous Injection Immunoglobulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intravenous Injection Immunoglobulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intravenous Injection Immunoglobulin Market by Company

Boya-Bio

CTBB

Sinopharm

Beijing Tiantan Biological Products

Guangdong Shuagnlin Bio-pharmacy

Hualan Bio

Nanyue Biopharming

Shanghai RAAS

Weiguang Biological

Intravenous Injection Immunoglobulin Segment by Type

5g/100ml

2.5g/50ml

1g/20ml

10g/200ml

1.25g/25ml

Intravenous Injection Immunoglobulin Segment by Application

Hospital

Clinic

Others

Intravenous Injection Immunoglobulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Injection Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Injection Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Injection Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Injection Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intravenous Injection Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5g/100ml Table 2. Major Company of 2.5g/50ml Table 3. Major Company of 1g/20ml Table 4. Major Company of 10g/200ml Table 5. Major Company of 1.25g/25ml Table 6. Global Intravenous Injection Immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (L) Table 8. Global Intravenous Injection Immunoglobulin Sales Market Share in Volume by Type (2021-2026) Table 9. Global Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 10. Global Intravenous Injection Immunoglobulin Sales Market Share in Value by Type (2021-2026) Table 11. Global Intravenous Injection Immunoglobulin Price by Type (2021-2026) & (US$/ml) Table 12. Global Intravenous Injection Immunoglobulin Sales by Type (2027-2032) & (L) Table 13. Global Intravenous Injection Immunoglobulin Sales Market Share in Volume by Type (2027-2032) Table 14. Global Intravenous Injection Immunoglobulin Sales by Type (2027-2032) & (US$ Million) Table 15. Global Intravenous Injection Immunoglobulin Sales Market Share in Value by Type (2027-2032) Table 16. Global Intravenous Injection Immunoglobulin Price by Type (2027-2032) & (US$/ml) Table 17. North America Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (L) Table 18. North America Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (L) Table 20. Europe Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (L) Table 22. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (L) Table 24. Latin America Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (L) Table 26. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 27. Intravenous Injection Immunoglobulin Industry Trends Table 28. Intravenous Injection Immunoglobulin Industry Drivers Table 29. Intravenous Injection Immunoglobulin Industry Opportunities and Challenges Table 30. Intravenous Injection Immunoglobulin Industry Restraints Table 31. Global Intravenous Injection Immunoglobulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Intravenous Injection Immunoglobulin Revenue Market Share by Company (2021-2026) Table 33. Global Intravenous Injection Immunoglobulin Sales by Company (2021-2026) & (L) Table 34. Global Intravenous Injection Immunoglobulin Sales Share by Company (2021-2026) Table 35. Global Intravenous Injection Immunoglobulin Market Price by Company (2021-2026) & (US$/ml) Table 36. Global Intravenous Injection Immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Intravenous Injection Immunoglobulin Major Company Production Sites and Headquarters Table 38. Global Intravenous Injection Immunoglobulin Company, Product Type & Application Table 39. Global Intravenous Injection Immunoglobulin Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Intravenous Injection Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Intravenous Injection Immunoglobulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Intravenous Injection Immunoglobulin Sales by Region (2021-2026) & (L) Table 44. Global Intravenous Injection Immunoglobulin Sales Market Share in Volume by Region (2021-2026) Table 45. Global Intravenous Injection Immunoglobulin Sales by Region (2021-2026) & (US$ Million) Table 46. Global Intravenous Injection Immunoglobulin Sales Market Share in Value by Region (2021-2026) Table 47. Global Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 48. Global Intravenous Injection Immunoglobulin Sales by Region (2027-2032) & (L) Table 49. Global Intravenous Injection Immunoglobulin Sales Market Share in Volume by Region (2027-2032) Table 50. Global Intravenous Injection Immunoglobulin Sales by Region (2027-2032) & (US$ Million) Table 51. Global Intravenous Injection Immunoglobulin Sales Market Share in Value by Region (2027-2032) Table 52. Global Intravenous Injection Immunoglobulin Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2027-2032) Table 53. Global Intravenous Injection Immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (L) Table 55. Global Intravenous Injection Immunoglobulin Sales Market Share in Volume by Application (2021-2026) Table 56. Global Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 57. Global Intravenous Injection Immunoglobulin Sales Market Share in Value by Application (2021-2026) Table 58. Global Intravenous Injection Immunoglobulin Price by Application (2021-2026) & (US$/ml) Table 59. Global Intravenous Injection Immunoglobulin Sales by Application (2027-2032) & (L) Table 60. Global Intravenous Injection Immunoglobulin Sales Market Share in Volume by Application (2027-2032) Table 61. Global Intravenous Injection Immunoglobulin Sales by Application (2027-2032) & (US$ Million) Table 62. Global Intravenous Injection Immunoglobulin Sales Market Share in Value by Application (2027-2032) Table 63. Global Intravenous Injection Immunoglobulin Price by Application (2027-2032) & (US$/ml) Table 64. North America Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (L) Table 65. North America Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (L) Table 67. Europe Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (L) Table 69. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (L) Table 71. Latin America Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (L) Table 73. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 74. Boya-Bio Company Information Table 75. Boya-Bio Business Overview Table 76. Boya-Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 77. Boya-Bio Intravenous Injection Immunoglobulin Product Portfolio Table 78. Boya-Bio Recent Development Table 79. CTBB Company Information Table 80. CTBB Business Overview Table 81. CTBB Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 82. CTBB Intravenous Injection Immunoglobulin Product Portfolio Table 83. CTBB Recent Development Table 84. Sinopharm Company Information Table 85. Sinopharm Business Overview Table 86. Sinopharm Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 87. Sinopharm Intravenous Injection Immunoglobulin Product Portfolio Table 88. Sinopharm Recent Development Table 89. Beijing Tiantan Biological Products Company Information Table 90. Beijing Tiantan Biological Products Business Overview Table 91. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 92. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Portfolio Table 93. Beijing Tiantan Biological Products Recent Development Table 94. Guangdong Shuagnlin Bio-pharmacy Company Information Table 95. Guangdong Shuagnlin Bio-pharmacy Business Overview Table 96. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 97. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Portfolio Table 98. Guangdong Shuagnlin Bio-pharmacy Recent Development Table 99. Hualan Bio Company Information Table 100. Hualan Bio Business Overview Table 101. Hualan Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 102. Hualan Bio Intravenous Injection Immunoglobulin Product Portfolio Table 103. Hualan Bio Recent Development Table 104. Nanyue Biopharming Company Information Table 105. Nanyue Biopharming Business Overview Table 106. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 107. Nanyue Biopharming Intravenous Injection Immunoglobulin Product Portfolio Table 108. Nanyue Biopharming Recent Development Table 109. Shanghai RAAS Company Information Table 110. Shanghai RAAS Business Overview Table 111. Shanghai RAAS Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 112. Shanghai RAAS Intravenous Injection Immunoglobulin Product Portfolio Table 113. Shanghai RAAS Recent Development Table 114. Weiguang Biological Company Information Table 115. Weiguang Biological Business Overview Table 116. Weiguang Biological Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 117. Weiguang Biological Intravenous Injection Immunoglobulin Product Portfolio Table 118. Weiguang Biological Recent Development Table 119. North America Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 120. North America Intravenous Injection Immunoglobulin Sales by Country (2021-2026) & (L) Table 121. North America Intravenous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 122. North America Intravenous Injection Immunoglobulin Sales Forecast by Country (2027-2032) & (L) Table 123. North America Intravenous Injection Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 124. North America Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Intravenous Injection Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Intravenous Injection Immunoglobulin Market Share by Country (2021-2026) Table 127. North America Intravenous Injection Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Intravenous Injection Immunoglobulin Market Share Forecast by Country (2027-2032) Table 129. Europe Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 130. Europe Intravenous Injection Immunoglobulin Sales by Country (2021-2026) & (L) Table 131. Europe Intravenous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 132. Europe Intravenous Injection Immunoglobulin Sales Forecast by Country (2027-2032) & (L) Table 133. Europe Intravenous Injection Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Intravenous Injection Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Intravenous Injection Immunoglobulin Market Share by Country (2021-2026) Table 137. Europe Intravenous Injection Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Intravenous Injection Immunoglobulin Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Country (2021-2026) & (L) Table 141. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Intravenous Injection Immunoglobulin Sales Forecast by Country (2027-2032) & (L) Table 143. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Intravenous Injection Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Intravenous Injection Immunoglobulin Market Share by Country (2021-2026) Table 147. Asia-Pacific Intravenous Injection Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Intravenous Injection Immunoglobulin Market Share Forecast by Country (2027-2032) Table 149. Latin America Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 150. Latin America Intravenous Injection Immunoglobulin Sales by Country (2021-2026) & (L) Table 151. Latin America Intravenous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 152. Latin America Intravenous Injection Immunoglobulin Sales Forecast by Country (2027-2032) & (L) Table 153. Latin America Intravenous Injection Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Intravenous Injection Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Intravenous Injection Immunoglobulin Market Share by Country (2021-2026) Table 157. Latin America Intravenous Injection Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Intravenous Injection Immunoglobulin Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2021-2026) & (L) Table 161. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Intravenous Injection Immunoglobulin Sales Forecast by Country (2027-2032) & (L) Table 163. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Intravenous Injection Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Intravenous Injection Immunoglobulin Market Share by Country (2021-2026) Table 167. Middle East and Africa Intravenous Injection Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Intravenous Injection Immunoglobulin Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Intravenous Injection Immunoglobulin Distributors List Table 172. Intravenous Injection Immunoglobulin Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Intravenous Injection Immunoglobulin Image Figure 2. Global Intravenous Injection Immunoglobulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Injection Immunoglobulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Injection Immunoglobulin Sales (2021-2032) & (L) Figure 5. 5g/100ml Image Figure 6. Global 5g/100ml Sales YoY Growth (2021-2032) & (L) Figure 7. 2.5g/50ml Image Figure 8. Global 2.5g/50ml Sales YoY Growth (2021-2032) & (L) Figure 9. 1g/20ml Image Figure 10. Global 1g/20ml Sales YoY Growth (2021-2032) & (L) Figure 11. 10g/200ml Image Figure 12. Global 10g/200ml Sales YoY Growth (2021-2032) & (L) Figure 13. 1.25g/25ml Image Figure 14. Global 1.25g/25ml Sales YoY Growth (2021-2032) & (L) Figure 15. Global Intravenous Injection Immunoglobulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Intravenous Injection Immunoglobulin Market Share by Type 2025 VS 2032 Figure 17. North America Intravenous Injection Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 18. North America Intravenous Injection Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 19. Europe Intravenous Injection Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 20. Europe Intravenous Injection Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 23. Latin America Intravenous Injection Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Intravenous Injection Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Intravenous Injection Immunoglobulin Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (L) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (L) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (L) Figure 35. Global Intravenous Injection Immunoglobulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Intravenous Injection Immunoglobulin Market Share by Application 2025 VS 2032 Figure 37. North America Intravenous Injection Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 38. North America Intravenous Injection Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 39. Europe Intravenous Injection Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 40. Europe Intravenous Injection Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 43. Latin America Intravenous Injection Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Intravenous Injection Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 47. North America Intravenous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 48. North America Intravenous Injection Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Intravenous Injection Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Intravenous Injection Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Intravenous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 52. Europe Intravenous Injection Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Intravenous Injection Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Intravenous Injection Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 56. Asia-Pacific Intravenous Injection Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Intravenous Injection Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Intravenous Injection Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Intravenous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 60. Latin America Intravenous Injection Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Intravenous Injection Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Intravenous Injection Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 64. Middle East and Africa Intravenous Injection Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Intravenous Injection Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Intravenous Injection Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Intravenous Injection Immunoglobulin Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Intravenous Injection Immunoglobulin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 5g/100ml
  • 2.5g/50ml
  • 1g/20ml
  • 10g/200ml
  • 1.25g/25ml
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boya-Bio
  • CTBB
  • Sinopharm
  • Beijing Tiantan Biological Products
  • Guangdong Shuagnlin Bio-pharmacy
  • Hualan Bio
  • Nanyue Biopharming
  • Shanghai RAAS
  • Weiguang Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Injection Immunoglobulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intravenous Injection Immunoglobulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intravenous Injection Immunoglobulin Market by Type
  6. 1.3.1 5g/100ml
  7. 1.3.2 2.5g/50ml
  8. 1.3.3 1g/20ml
  9. 1.3.4 10g/200ml
  10. 1.3.5 1.25g/25ml
  11. 1.4 Global Intravenous Injection Immunoglobulin Market Size by Type
  12. 1.4.1 Global Intravenous Injection Immunoglobulin Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Intravenous Injection Immunoglobulin Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Intravenous Injection Immunoglobulin Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Intravenous Injection Immunoglobulin Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Intravenous Injection Immunoglobulin Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Intravenous Injection Immunoglobulin Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Intravenous Injection Immunoglobulin Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Intravenous Injection Immunoglobulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intravenous Injection Immunoglobulin Industry Trends
  2. 2.2 Intravenous Injection Immunoglobulin Industry Drivers
  3. 2.3 Intravenous Injection Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Intravenous Injection Immunoglobulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intravenous Injection Immunoglobulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Intravenous Injection Immunoglobulin Sales (2021-2026)
  3. 3.3 Global Top Players by Intravenous Injection Immunoglobulin Price (2021-2026)
  4. 3.4 Global Intravenous Injection Immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Injection Immunoglobulin Major Company Production Sites & Headquarters
  6. 3.6 Global Intravenous Injection Immunoglobulin Company, Product Type & Application
  7. 3.7 Global Intravenous Injection Immunoglobulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Injection Immunoglobulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Injection Immunoglobulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Injection Immunoglobulin Tier 1, Tier 2, and Tier 3
4 Intravenous Injection Immunoglobulin Regional Status and Outlook
  1. 4.1 Global Intravenous Injection Immunoglobulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intravenous Injection Immunoglobulin Historic Market Size by Region
  3. 4.2.1 Global Intravenous Injection Immunoglobulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intravenous Injection Immunoglobulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intravenous Injection Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intravenous Injection Immunoglobulin Forecasted Market Size by Region
  7. 4.3.1 Global Intravenous Injection Immunoglobulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intravenous Injection Immunoglobulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intravenous Injection Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intravenous Injection Immunoglobulin by Application
  1. 5.1 Intravenous Injection Immunoglobulin Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Injection Immunoglobulin Market Size by Application
  6. 5.2.1 Global Intravenous Injection Immunoglobulin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Intravenous Injection Immunoglobulin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Intravenous Injection Immunoglobulin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Intravenous Injection Immunoglobulin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Intravenous Injection Immunoglobulin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Intravenous Injection Immunoglobulin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Intravenous Injection Immunoglobulin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Intravenous Injection Immunoglobulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boya-Bio
  2. 6.1.1 Boya-Bio Company Information
  3. 6.1.2 Boya-Bio Business Overview
  4. 6.1.3 Boya-Bio Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boya-Bio Intravenous Injection Immunoglobulin Product Portfolio
  6. 6.1.5 Boya-Bio Recent Developments
  7. 6.2 CTBB
  8. 6.2.1 CTBB Company Information
  9. 6.2.2 CTBB Business Overview
  10. 6.2.3 CTBB Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CTBB Intravenous Injection Immunoglobulin Product Portfolio
  12. 6.2.5 CTBB Recent Developments
  13. 6.3 Sinopharm
  14. 6.3.1 Sinopharm Company Information
  15. 6.3.2 Sinopharm Business Overview
  16. 6.3.3 Sinopharm Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sinopharm Intravenous Injection Immunoglobulin Product Portfolio
  18. 6.3.5 Sinopharm Recent Developments
  19. 6.4 Beijing Tiantan Biological Products
  20. 6.4.1 Beijing Tiantan Biological Products Company Information
  21. 6.4.2 Beijing Tiantan Biological Products Business Overview
  22. 6.4.3 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Portfolio
  24. 6.4.5 Beijing Tiantan Biological Products Recent Developments
  25. 6.5 Guangdong Shuagnlin Bio-pharmacy
  26. 6.5.1 Guangdong Shuagnlin Bio-pharmacy Company Information
  27. 6.5.2 Guangdong Shuagnlin Bio-pharmacy Business Overview
  28. 6.5.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Portfolio
  30. 6.5.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments
  31. 6.6 Hualan Bio
  32. 6.6.1 Hualan Bio Company Information
  33. 6.6.2 Hualan Bio Business Overview
  34. 6.6.3 Hualan Bio Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hualan Bio Intravenous Injection Immunoglobulin Product Portfolio
  36. 6.6.5 Hualan Bio Recent Developments
  37. 6.7 Nanyue Biopharming
  38. 6.7.1 Nanyue Biopharming Company Information
  39. 6.7.2 Nanyue Biopharming Business Overview
  40. 6.7.3 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nanyue Biopharming Intravenous Injection Immunoglobulin Product Portfolio
  42. 6.7.5 Nanyue Biopharming Recent Developments
  43. 6.8 Shanghai RAAS
  44. 6.8.1 Shanghai RAAS Company Information
  45. 6.8.2 Shanghai RAAS Business Overview
  46. 6.8.3 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai RAAS Intravenous Injection Immunoglobulin Product Portfolio
  48. 6.8.5 Shanghai RAAS Recent Developments
  49. 6.9 Weiguang Biological
  50. 6.9.1 Weiguang Biological Company Information
  51. 6.9.2 Weiguang Biological Business Overview
  52. 6.9.3 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Weiguang Biological Intravenous Injection Immunoglobulin Product Portfolio
  54. 6.9.5 Weiguang Biological Recent Developments
7 North America by Country
  1. 7.1 North America Intravenous Injection Immunoglobulin Sales by Country
  2. 7.1.1 North America Intravenous Injection Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intravenous Injection Immunoglobulin Sales by Country (2021-2026)
  4. 7.1.3 North America Intravenous Injection Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intravenous Injection Immunoglobulin Market Size by Country
  6. 7.2.1 North America Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intravenous Injection Immunoglobulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Intravenous Injection Immunoglobulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intravenous Injection Immunoglobulin Sales by Country
  2. 8.1.1 Europe Intravenous Injection Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intravenous Injection Immunoglobulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Intravenous Injection Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intravenous Injection Immunoglobulin Market Size by Country
  6. 8.2.1 Europe Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intravenous Injection Immunoglobulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intravenous Injection Immunoglobulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intravenous Injection Immunoglobulin Sales by Country
  2. 9.1.1 Asia-Pacific Intravenous Injection Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intravenous Injection Immunoglobulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intravenous Injection Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intravenous Injection Immunoglobulin Market Size by Country
  6. 9.2.1 Asia-Pacific Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intravenous Injection Immunoglobulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intravenous Injection Immunoglobulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intravenous Injection Immunoglobulin Sales by Country
  2. 10.1.1 South America Intravenous Injection Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intravenous Injection Immunoglobulin Sales by Country (2021-2026)
  4. 10.1.3 South America Intravenous Injection Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intravenous Injection Immunoglobulin Market Size by Country
  6. 10.2.1 South America Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intravenous Injection Immunoglobulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Intravenous Injection Immunoglobulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country
  2. 11.1.1 Middle East and Africa Intravenous Injection Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intravenous Injection Immunoglobulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intravenous Injection Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intravenous Injection Immunoglobulin Market Size by Country
  6. 11.2.1 Middle East and Africa Intravenous Injection Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intravenous Injection Immunoglobulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intravenous Injection Immunoglobulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intravenous Injection Immunoglobulin Value Chain Analysis
  2. 12.1.1 Intravenous Injection Immunoglobulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intravenous Injection Immunoglobulin Production Mode & Process
  7. 12.2 Intravenous Injection Immunoglobulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intravenous Injection Immunoglobulin Distributors
  10. 12.2.3 Intravenous Injection Immunoglobulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst